TrialPloS one2023

Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.

Patricia Volkow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.